Association Between Nonalcoholic Fatty Liver Disease and Carotid Artery Inflammation Evaluated by 18F-Fluorodeoxyglucose Positron Emission Tomography

Angiology

Volumn 66, Issue 5, 2015, Pages 472-480

  Moon, Seung Hwan ^a   Noh, Tae Soo ^a   Cho, Young Seok ^a   Hong, Seon Pyo ^a   Hyun, Seung Hyup ^a   Choi, Joon Young ^a   Kim, Byung Tae ^a   Lee, Kyung Han ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

atherosclerosis; carotid artery; FDG; nonalcoholic fatty liver disease; PET CT

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; FLUORODEOXYGLUCOSE F 18; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTERIAL WALL THICKNESS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ATHEROSCLEROTIC PLAQUE; CAROTID ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOGRAPHY; FRAMINGHAM RISK SCORE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; NONALCOHOLIC FATTY LIVER; PET-CT SCANNER; POSITRON EMISSION TOMOGRAPHY; REAL TIME ULTRASOUND SCANNER; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL; CAROTID ARTERY DISEASE; CHI SQUARE DISTRIBUTION; COMPLICATION; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC USE; MIDDLE AGED; MULTIMODAL IMAGING; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE; RADIOGRAPHY; RISK; SCINTISCANNING; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CAROTID ARTERY DISEASES; CAROTID INTIMA-MEDIA THICKNESS; CHI-SQUARE DISTRIBUTION; FLUORODEOXYGLUCOSE F18; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIMODAL IMAGING; MULTIVARIATE ANALYSIS; NON-ALCOHOLIC FATTY LIVER DISEASE; ODDS RATIO; PLAQUE, ATHEROSCLEROTIC; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84928023621     PISSN: 00033197     EISSN: 19401574     Source Type: Journal    
DOI: 10.1177/0003319714537872     Document Type: Article

References (39)

1. Targher G, Day CP, Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med. 2010 ; 363 (14). 1341-1350
2. Kim CH, Younossi ZM. Nonalcoholic fatty liver disease: a manifestation of the metabolic syndrome. Cleve Clin J Med. 2008 ; 75 (10). 721-728
3. Targher G, Marra F, Marchesini G. Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon?. Diabetologia. 2008 ; 51 (11). 1947-1953
4. Kim NH, Park J, Kim SH, et al. Non-alcoholic fatty liver disease, metabolic syndrome and subclinical cardiovascular changes in the general population. Heart. 2014 ; 100 (12). 938-943
5. Brea A, Mosquera D, Martin E, Arizti A, Cordero JL, Ros E. Nonalcoholic fatty liver disease is associated with carotid atherosclerosis: a case-control study. Arterioscler Thromb Vasc Biol. 2005 ; 25 (5). 1045-1050
6. Huang Y, Bi Y, Xu M, et al. Nonalcoholic fatty liver disease is associated with atherosclerosis in middle-aged and elderly Chinese. Arterioscler Thromb Vasc Biol. 2012 ; 32 (9). 2321-2326
7. Carallo C, Mancuso G, Mauro G, et al. Hepatic steatosis, carotid atherosclerosis and metabolic syndrome: the STEATO Study. J Gastroenterol. 2009 ; 44 (11). 1156-1161
8. Kim SK, Choi YJ, Huh BW, et al. Non-alcoholic fatty liver disease is associated with increased carotid intima-media thickness only in type 2 diabetic subjects with insulin resistance. J Clin Endocrinol Metab. 2014 ; 99 (5). 1879-1884
9. Thakur ML, Sharma S, Kumar A, et al. Nonalcoholic fatty liver disease is associated with subclinical atherosclerosis independent of obesity and metabolic syndrome in Asian Indians. Atherosclerosis. 2012 ; 223 (2). 507-511
10. Sookoian S, Pirola CJ. Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: a systematic review. J Hepatol. 2008 ; 49 (4). 600-607
11. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med. 1999 ; 340 (2). 115-126
12. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002 ; 105 (9). 1135-1143
13. Choi YS, Youn HJ, Chung WB, et al. Uptake of F-18 FDG and ultrasound analysis of carotid plaque. J Nucl Cardiol. 2011 ; 18 (2). 267-272
14. Jezovnik MK, Zidar N, Lezaic L, Gersak B, Poredos P. Identification of inflamed atherosclerotic lesions in vivo using PET-CT. Inflammation. 2014 ; 37 (2). 426-434
15. Joshi F, Rosenbaum D, Bordes S, Rudd JH. Vascular imaging with positron emission tomography. J Intern Med. 2011 ; 270 (2). 99-109
16. Paulmier B, Duet M, Khayat R, et al. Arterial wall uptake of fluorodeoxyglucose on PET imaging in stable cancer disease patients indicates higher risk for cardiovascular events. J Nucl Cardiol. 2008 ; 15 (2). 209-217
17. D'Agostino RB Sr., Vasan RS, Pencina MJ, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008 ; 117 (6). 743-753
18. Noh TS, Moon SH, Cho YS, et al. Relation of carotid artery 18F-FDG uptake to C-reactive protein and Framingham risk score in a large cohort of asymptomatic adults. J Nucl Med. 2013 ; 54 (12). 2070-2076
19. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome - a new world-wide definition. A consensus statement from the international diabetes federation. Diabet Med. 2006 ; 23 (5). 469-480
20. Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009 ; 120 (16). 1640-1645
21. James WP, Chunming C, Inoue S. Appropriate Asian body mass indices?. Obes Rev. 2002 ; 3 (3). 139
22. Weisell RC. Body mass index as an indicator of obesity. Asia Pac J Clin Nutr. 2002 ; 11 suppl 8: S681 - S684
23. Khashab MA, Liangpunsakul S, Chalasani N. Nonalcoholic fatty liver disease as a component of the metabolic syndrome. Curr Gastroenterol Rep. 2008 ; 10 (1). 73-80
24. Moore JB. Non-alcoholic fatty liver disease: the hepatic consequence of obesity and the metabolic syndrome. Proc Nutr Soc. 2010 ; 69 (2). 211-220
25. Tahara N, Kai H, Yamagishi S, et al. Vascular inflammation evaluated by [18F]-fluorodeoxyglucose positron emission tomography is associated with the metabolic syndrome. J Am Coll Cardiol. 2007 ; 49 (14). 1533-1539
26. Dick TJ, Lesser IA, Leipsic JA, Mancini GB, Lear SA. The effect of obesity on the association between liver fat and carotid atherosclerosis in a multi-ethnic cohort. Atherosclerosis. 2013 ; 226 (1). 208-213
27. Marchesini G, Brizi M, Bianchi G, et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes. 2001 ; 50 (8). 1844-1850
28. Marchesini G, Avagnina S, Barantani EG, et al. Aminotransferase and gamma-glutamyltranspeptidase levels in obesity are associated with insulin resistance and the metabolic syndrome. J Endocrinol Invest. 2005 ; 28 (4). 333-339
29. Eroglu S, Sade LE, Polat E, Bozbas H, Ulus T, Muderrisoglu H. Association between serum gamma-glutamyltransferase activity and carotid intima-media thickness. Angiology. 2011 ; 62 (2). 107-110
30. Wang CC, Lin SK, Tseng YF, et al. Elevation of serum aminotransferase activity increases risk of carotid atherosclerosis in patients with non-alcoholic fatty liver disease. J Gastroenterol Hepatol. 2009 ; 24 (8). 1411-1416
31. Yun M, Jang S, Cucchiara A, Newberg AB, Alavi A. 18F FDG uptake in the large arteries: a correlation study with the atherogenic risk factors. Semin Nucl Med. 2002 ; 32 (1). 70-76
32. Bucerius J, Duivenvoorden R, Mani V, et al. Prevalence and risk factors of carotid vessel wall inflammation in coronary artery disease patients: FDG-PET and CT imaging study. JACC Cardiovasc Imaging. 2011 ; 4 (11). 1195-1205
33. Timoteo AT, Carmo MM, Ferreira RC. Carotid intima-media thickness and carotid plaques improves prediction of obstructive angiographic coronary artery disease in women. Angiology. 2013 ; 64 (1). 57-63
34. Agac MT, Korkmaz L, Cavusoglu G, et al. Association between nonalcoholic fatty liver disease and coronary artery disease complexity in patients with acute coronary syndrome: a pilot study. Angiology. 2013 ; 64 (8). 604-608
35. Jeevarethinam A, Venuraju S, Weymouth M, Atwal S, Lahiri A. Carotid intimal thickness and plaque predict prevalence and severity of coronary atherosclerosis: a pilot study. Angiology. 2015 ; 66 (1). 65-69
36. Lorenz MW, Schaefer C, Steinmetz H, Sitzer M. Is carotid intima media thickness useful for individual prediction of cardiovascular risk? Ten-year results from the Carotid Atherosclerosis Progression Study (CAPS). Eur Heart J. 2010 ; 31 (16). 2041-2048
37. Khot UN, Khot MB, Bajzer CT, et al. Prevalence of conventional risk factors in patients with coronary heart disease. JAMA. 2003 ; 290 (7). 898-904
38. Ma X, Holalkere NS, Kambadakone RA, Mino-Kenudson M, Hahn PF, Sahani DV. Imaging-based quantification of hepatic fat: methods and clinical applications. Radiographics. 2009 ; 29 (5). 1253-1277
39. Sinn DH, Gwak GY, Cho J, et al. Modest alcohol consumption and carotid plaques or carotid artery stenosis in men with non-alcoholic fatty liver disease. Atherosclerosis. 2014 ; 234 (2). 270-275